Loading…

Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases

Ral GTPases have been implicated as critical drivers of cell growth and metastasis in numerous Ras-driven cancers. We have previously reported stapled peptides, based on the Ral effector RLIP76, that can disrupt Ral signaling. Stapled peptides are short peptides that are locked into their bioactive...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2020-11, Vol.296, p.100101
Main Authors: Hurd, Catherine A, Brear, Paul, Revell, Jefferson, Ross, Sarah, Mott, Helen R, Owen, Darerca
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 100101
container_title The Journal of biological chemistry
container_volume 296
creator Hurd, Catherine A
Brear, Paul
Revell, Jefferson
Ross, Sarah
Mott, Helen R
Owen, Darerca
description Ral GTPases have been implicated as critical drivers of cell growth and metastasis in numerous Ras-driven cancers. We have previously reported stapled peptides, based on the Ral effector RLIP76, that can disrupt Ral signaling. Stapled peptides are short peptides that are locked into their bioactive form using a synthetic brace. Here, using an affinity maturation of the RLIP76 Ral-binding domain, we identified several sequence substitutions that together improve binding to Ral proteins by more than 20-fold. Hits from the selection were rigorously analyzed to determine the contributions of individual residues and two 1.5 Å cocrystal structures of the tightest-binding mutants in complex with RalB revealed key interactions. Insights gained from this maturation were used to design second-generation stapled peptides based on RLIP76 that exhibited vastly improved selectivity for Ral GTPases when compared with the first-generation lead peptide. The binding of second-generation peptides to Ral proteins was quantified and the binding site of the lead peptide on RalB was determined by NMR. Stapled peptides successfully competed with multiple Ral-effector interactions in cellular lysates. Our findings demonstrate how manipulation of a native binding partner can assist in the rational design of stapled peptide inhibitors targeting a protein-protein interaction.
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_33410415</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33410415</sourcerecordid><originalsourceid>FETCH-pubmed_primary_334104153</originalsourceid><addsrcrecordid>eNqFjsuKAjEURMOA-BjnF4b7A0KHtOO4HAZf4ELEhTu5kqS90nmQXBH_3rbRtbUpKE4V9SH6svhVIzWW-54Y5HwuGpVT2RU9pUpZlHLcF9c_a8kT38AhXxIyBQ_BAp8MbNerzeQHtljDkbwmX4EODskDByBvQ3Itp02mqm1lxlgbDdFEpiYGxlQZfjTbwWZpsdtgNnkoOhbrbL6e_im-57Pd_3IUL0dn9CEmcphuh9dT9Ra4A3EUSZA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases</title><source>ScienceDirect (Online service)</source><source>PubMed Central</source><creator>Hurd, Catherine A ; Brear, Paul ; Revell, Jefferson ; Ross, Sarah ; Mott, Helen R ; Owen, Darerca</creator><creatorcontrib>Hurd, Catherine A ; Brear, Paul ; Revell, Jefferson ; Ross, Sarah ; Mott, Helen R ; Owen, Darerca</creatorcontrib><description>Ral GTPases have been implicated as critical drivers of cell growth and metastasis in numerous Ras-driven cancers. We have previously reported stapled peptides, based on the Ral effector RLIP76, that can disrupt Ral signaling. Stapled peptides are short peptides that are locked into their bioactive form using a synthetic brace. Here, using an affinity maturation of the RLIP76 Ral-binding domain, we identified several sequence substitutions that together improve binding to Ral proteins by more than 20-fold. Hits from the selection were rigorously analyzed to determine the contributions of individual residues and two 1.5 Å cocrystal structures of the tightest-binding mutants in complex with RalB revealed key interactions. Insights gained from this maturation were used to design second-generation stapled peptides based on RLIP76 that exhibited vastly improved selectivity for Ral GTPases when compared with the first-generation lead peptide. The binding of second-generation peptides to Ral proteins was quantified and the binding site of the lead peptide on RalB was determined by NMR. Stapled peptides successfully competed with multiple Ral-effector interactions in cellular lysates. Our findings demonstrate how manipulation of a native binding partner can assist in the rational design of stapled peptide inhibitors targeting a protein-protein interaction.</description><identifier>EISSN: 1083-351X</identifier><identifier>PMID: 33410415</identifier><language>eng</language><publisher>United States</publisher><ispartof>The Journal of biological chemistry, 2020-11, Vol.296, p.100101</ispartof><rights>Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33410415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hurd, Catherine A</creatorcontrib><creatorcontrib>Brear, Paul</creatorcontrib><creatorcontrib>Revell, Jefferson</creatorcontrib><creatorcontrib>Ross, Sarah</creatorcontrib><creatorcontrib>Mott, Helen R</creatorcontrib><creatorcontrib>Owen, Darerca</creatorcontrib><title>Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Ral GTPases have been implicated as critical drivers of cell growth and metastasis in numerous Ras-driven cancers. We have previously reported stapled peptides, based on the Ral effector RLIP76, that can disrupt Ral signaling. Stapled peptides are short peptides that are locked into their bioactive form using a synthetic brace. Here, using an affinity maturation of the RLIP76 Ral-binding domain, we identified several sequence substitutions that together improve binding to Ral proteins by more than 20-fold. Hits from the selection were rigorously analyzed to determine the contributions of individual residues and two 1.5 Å cocrystal structures of the tightest-binding mutants in complex with RalB revealed key interactions. Insights gained from this maturation were used to design second-generation stapled peptides based on RLIP76 that exhibited vastly improved selectivity for Ral GTPases when compared with the first-generation lead peptide. The binding of second-generation peptides to Ral proteins was quantified and the binding site of the lead peptide on RalB was determined by NMR. Stapled peptides successfully competed with multiple Ral-effector interactions in cellular lysates. Our findings demonstrate how manipulation of a native binding partner can assist in the rational design of stapled peptide inhibitors targeting a protein-protein interaction.</description><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFjsuKAjEURMOA-BjnF4b7A0KHtOO4HAZf4ELEhTu5kqS90nmQXBH_3rbRtbUpKE4V9SH6svhVIzWW-54Y5HwuGpVT2RU9pUpZlHLcF9c_a8kT38AhXxIyBQ_BAp8MbNerzeQHtljDkbwmX4EODskDByBvQ3Itp02mqm1lxlgbDdFEpiYGxlQZfjTbwWZpsdtgNnkoOhbrbL6e_im-57Pd_3IUL0dn9CEmcphuh9dT9Ra4A3EUSZA</recordid><startdate>20201123</startdate><enddate>20201123</enddate><creator>Hurd, Catherine A</creator><creator>Brear, Paul</creator><creator>Revell, Jefferson</creator><creator>Ross, Sarah</creator><creator>Mott, Helen R</creator><creator>Owen, Darerca</creator><scope>NPM</scope></search><sort><creationdate>20201123</creationdate><title>Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases</title><author>Hurd, Catherine A ; Brear, Paul ; Revell, Jefferson ; Ross, Sarah ; Mott, Helen R ; Owen, Darerca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_334104153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hurd, Catherine A</creatorcontrib><creatorcontrib>Brear, Paul</creatorcontrib><creatorcontrib>Revell, Jefferson</creatorcontrib><creatorcontrib>Ross, Sarah</creatorcontrib><creatorcontrib>Mott, Helen R</creatorcontrib><creatorcontrib>Owen, Darerca</creatorcontrib><collection>PubMed</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hurd, Catherine A</au><au>Brear, Paul</au><au>Revell, Jefferson</au><au>Ross, Sarah</au><au>Mott, Helen R</au><au>Owen, Darerca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2020-11-23</date><risdate>2020</risdate><volume>296</volume><spage>100101</spage><pages>100101-</pages><eissn>1083-351X</eissn><abstract>Ral GTPases have been implicated as critical drivers of cell growth and metastasis in numerous Ras-driven cancers. We have previously reported stapled peptides, based on the Ral effector RLIP76, that can disrupt Ral signaling. Stapled peptides are short peptides that are locked into their bioactive form using a synthetic brace. Here, using an affinity maturation of the RLIP76 Ral-binding domain, we identified several sequence substitutions that together improve binding to Ral proteins by more than 20-fold. Hits from the selection were rigorously analyzed to determine the contributions of individual residues and two 1.5 Å cocrystal structures of the tightest-binding mutants in complex with RalB revealed key interactions. Insights gained from this maturation were used to design second-generation stapled peptides based on RLIP76 that exhibited vastly improved selectivity for Ral GTPases when compared with the first-generation lead peptide. The binding of second-generation peptides to Ral proteins was quantified and the binding site of the lead peptide on RalB was determined by NMR. Stapled peptides successfully competed with multiple Ral-effector interactions in cellular lysates. Our findings demonstrate how manipulation of a native binding partner can assist in the rational design of stapled peptide inhibitors targeting a protein-protein interaction.</abstract><cop>United States</cop><pmid>33410415</pmid></addata></record>
fulltext fulltext
identifier EISSN: 1083-351X
ispartof The Journal of biological chemistry, 2020-11, Vol.296, p.100101
issn 1083-351X
language eng
recordid cdi_pubmed_primary_33410415
source ScienceDirect (Online service); PubMed Central
title Affinity maturation of the RLIP76 Ral binding domain to inform the design of stapled peptides targeting the Ral GTPases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A24%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Affinity%20maturation%20of%20the%20RLIP76%20Ral%20binding%20domain%20to%20inform%20the%20design%20of%20stapled%20peptides%20targeting%20the%20Ral%20GTPases&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Hurd,%20Catherine%20A&rft.date=2020-11-23&rft.volume=296&rft.spage=100101&rft.pages=100101-&rft.eissn=1083-351X&rft_id=info:doi/&rft_dat=%3Cpubmed%3E33410415%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-pubmed_primary_334104153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/33410415&rfr_iscdi=true